ISRG · Earnings call · 2026Q3T · Full report

Product Launch and Transition

INTUITIVE SURGICAL INC · 2026-10-20 · Importance 61 · Surprise 66

Da Vinci system placements increased 28% worldwide, with da Vinci 5 and SP accounting for 65% of placements; installations of XiR and X more than doubled. Intuitive exited the quarter with more than 2,000 da Vinci 5 systems installed, used by over 18,000 surgeons since launch, and management reported demand for both capacity expansion and upgrades. SP procedures are expanding as clearances and instrumentation broaden, including adoption of the new SP stapler; the company planned a U.S. submission for the SP vessel sealer in Q4. XiR is being used in the U.S. and internationally to build programs around focused procedure sets, with customers citing its familiarity, capabilities, and cost profile.

Key facts

• Intuitive plans to submit the SP vessel sealer in the U.S. in Q4 2026.
• Installations of XiR and X more than doubled in Q3 2026.
• In Q3 2026, Intuitive received CE marks for Force Feedback instrumentation and cardiac procedures on da Vinci 5, and transvaginal gynecological procedures on SP.
• Intuitive placed a record 42 SP systems in Q3 2026, including 21 in the U.S. and 12 in Korea; the SP installed base increased 42% year over year to 487 systems.
• In Q3 2026, U.S. da Vinci net placements increased 41%.
• Da Vinci 5 was cleared for cardiac procedures in the U.S., Europe, India, Japan and Korea as of Q3 2026.
• Da Vinci 5 accounted for more than one-quarter of U.S. procedures in Q3 2026, up from 13% a year earlier.
• In Q3 2026, worldwide da Vinci system placements increased 28%, and da Vinci 5 and SP accounted for 65% of global placements.